1. Home
  2. WS vs ZYME Comparison

WS vs ZYME Comparison

Compare WS & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Steel Inc.

WS

Worthington Steel Inc.

HOLD

Current Price

$36.00

Market Cap

1.8B

Sector

N/A

ML Signal

HOLD

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$26.98

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WS
ZYME
Founded
1955
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
WS
ZYME
Price
$36.00
$26.98
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$37.50
$30.67
AVG Volume (30 Days)
271.3K
963.2K
Earning Date
12-17-2025
11-06-2025
Dividend Yield
1.76%
N/A
EPS Growth
N/A
N/A
EPS
2.47
N/A
Revenue
$3,265,100,000.00
$134,481,000.00
Revenue This Year
$12.50
$64.45
Revenue Next Year
$3.97
$67.04
P/E Ratio
$14.71
N/A
Revenue Growth
N/A
116.21
52 Week Low
$21.30
$9.03
52 Week High
$38.59
$28.49

Technical Indicators

Market Signals
Indicator
WS
ZYME
Relative Strength Index (RSI) 62.92 65.59
Support Level $34.34 $24.88
Resistance Level $38.59 $26.55
Average True Range (ATR) 1.42 1.13
MACD -0.05 -0.21
Stochastic Oscillator 43.84 84.07

Price Performance

Historical Comparison
WS
ZYME

About WS Worthington Steel Inc.

Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: